Chengdu Jinweike Biotechnology Co.
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- Undisclosed
Investors
- 2
About Chengdu Jinweike Biotechnology Co.
, Ltd operates as a biopharmaceutical company that focuses on gene therapy for hereditary diseases, cardiovascular and cerebrovascular diseases, and neurodegenerative diseases. It has established a 3,000 square AAV novel gene drugs R&D platform, including GMP AAV production facilities, GMP plasmid production facilities, quality control, and animal experiment platforms. The founder as well as the Chief Scientist Officer, Yuquan Wei, is a member of the Chinese Academy of Sciences, and former vice president of Sichuan University. The founder as well as the CEO, Yang Yang, has published more than 30 SCI papers and applied for 4 patents. The company's services can be categorized into AAV production service for R&D, and preparation of clinical grade AAV. Gene Vector has 12 different AAV serotypes to choose from, and provides customers with purified AAV virus, and quality control including the titer, purity, and endotoxin test reports. The company has established a technology platform with AAV capsid modification, gene expression cassette design, large gene delivery, and gene editing as its core. Its product pipeline is deployed in the fields of ophthalmic diseases, neuromuscular diseases, genetic metabolic diseases, etc. The company generates revenue by developing and providing AAV new drug candidates for wet macular degeneration.
Who invested in Chengdu Jinweike Biotechnology Co.
2 investors across 1 round
See all investors in Chengdu Jinweike Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 7, 2025
Amount
Undisclosed
Investors
Questions about Chengdu Jinweike Biotechnology Co.
Who invested in Chengdu Jinweike Biotechnology Co.?
Chengdu Jinweike Biotechnology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chengdu Jinweike Biotechnology Co. raised?
Chengdu Jinweike Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Chengdu Jinweike Biotechnology Co. last raise money?
Chengdu Jinweike Biotechnology Co.'s most recent round on record is a Series A, in Jan 2025.
What does Chengdu Jinweike Biotechnology Co. do?
, Ltd operates as a biopharmaceutical company that focuses on gene therapy for hereditary diseases, cardiovascular and cerebrovascular diseases, and neurodegenerative diseases.
Where is Chengdu Jinweike Biotechnology Co. headquartered?
Chengdu Jinweike Biotechnology Co. is headquartered in Chengdu, China.
Which VCs invest in companies like Chengdu Jinweike Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Chengdu Jinweike Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Chengdu Jinweike Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.